Skip to main content

Staying

 The "Solidarity" trials to for clinical research for COVID-19 should be accompanied by strong sustainability and ethics. There is no room for error, nor verbose sidestepping. It is important to be clear, direct and efficient for the public. 

* What will be done to assure diversity in trial reach for the six countries involved?

* Will the template for consent, IRB streamlining and other international work be formalized for continued use with future public health crises? 

* What will partnerships look like for pharmaceutical companies involved? What will medical home models look like for follow up, etc, and who will assure benefits of sustained delivery post-trial? 

* Rather than be moved around from location to location, forming and disrupting trusted community bonding, what will Solidarity trial planners do to assure long-term medical improvement build from these foundations? This includes local medical education, technological infrastructure support, pharmacy access, public health surveillance assistance, pharmaceutical corporate presence and allied health support in these countries. 


https://www.who.int/publications/m/item/weekly-update-on-covid-19-9-october-2020

Comments

Popular posts from this blog

Refugees, migrants and forcibly displaced persons

Continued pandemic management requires improved operations for forcibly displaced persons, migrants and refugees. Better organization for this population will expedite prevention and treatment for people, assist host countries and help prepare for future outbreaks. Organization for refugees, migrants and forcibly displaced persons should include:  * International oversight      R ecommendations and monetary awards for countries managing these populations should be supported with global analyses and follow up   .    Cohesive action should be driven by formal global planning, with experts at the table.    Real time analysis of host country needs and resources for the refugee and forcibly displaced population. If we are aware of the basics, we can improve real time analytics.  * Accountability    World Health Organization situational reports shape questions of accountability to epidemiological and surveillance improvements. E...

Beyond the Board

Sometimes it takes more than a board of directors to ensure an agency or government is safeguarding our interests. This is particularly true in regulation.  While a country's best interests may not align with international agenda, regulation on behalf of safety and protection is almost always universal. Workarounds to regulation, often allowed of out of self interest or cost, should be tied to international repercussions.  Regulation of food, markets, environmental epidemiology and other early prevention in novel strains make a difference.  Upcoming pandemics and outbreaks can be avoided, or at least better addressed, with better regulation. The international community should gather several policy points, measures and international comparisons. The international health community should observe, encourage and report on countries with and without these policies.  The end of the year COVID-19 WHO report is dynamic and impressive. It is missing policy development and in...

Party Bus

R egulatory approval across borders remain suboptimal. The suboptimal description is subjective, and our world has no way to measure optimal international regulatory efficiency. For all the work we have placed in international alignment, in every industry, we have yet to formalize evaluation measures on how we're doing.  International regulatory alignment is a fun party bus, yet many countries are reluctant to join. If we really trust one another, and our collegial backstory, we know we can join safely. Bus rides can perform stops, breaks when necessary, and rejoining when ready, but they can't wait forever for one to initially hop on. We don't have the option to join at any time, yet after we join, every option is available to us. A country that gets on the party bus remains in control alongside one another. This is especially important as we work toward better medicine for loved ones, for those seeing stars, and for everyone in the world.   Evaluate international r...